Gout’s Hidden Fire: Rethinking a Systemic Disease

Gout isn’t just a painful toe—it’s a systemic inflammatory condition linked to heart disease, kidney damage, and diabetes. This episode unpacks the paradigm shift in how medicine understands gout, from the NLRP3 inflammasome to IL-1 beta signaling. We explore the full treatment landscape: urate-lowering therapy with allopurinol and febuxostat, acute flare management with NSAIDs and colchicine, and emerging biologic options like canakinumab and anakinra. Plus, practical guidance on dosing, titration, and flare prophylaxis.